List of companies in SR One's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K. | ||||||
Decibel Therapeutics conducts inner ear research to deliver medicines for hearing and balance. | ||||||
A biopharmaceutical company that develops treatments for multi-drug resistant (MDR) bacterial infection | ||||||
A biopharmaceutical company developing T cell vaccines and immunotherapies | ||||||
Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens. | ||||||
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies. | ||||||
Focused on transforming lives of patients with immune dysfunctions and cancer | ||||||
MISSION Therapeutics is a Cambridge, Cambridgeshire-based biotechnology company offering a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes. | ||||||
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics | ||||||
Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies | ||||||
Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases. | ||||||
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases. | ||||||
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders. | ||||||
A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA. | ||||||
Avantium is a manufacturer of renewable and circular polymer materials founded in 2000. | ||||||
Biotechnology company developing medicines that target allosteric regulatory sites on proteins | ||||||
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract. | ||||||
F-star is an antibody Engineering founded in 2012. | ||||||
Spring Bank Pharmaceuticals, Inc. is a company founded in 2002 | ||||||
Bicycle Therapeutics is a Cambridge, Cambridgeshire-based company founded in 2009. | ||||||
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth. | ||||||
Applied Genetic Technologies Corporation is a gene Therapy founded in 1999. | ||||||
Progyny is a women's health company focused on fertility. | ||||||
Adaptive Immune Cell Therapies | ||||||
A company dedicated on the discovery and development of small molecule therapeutics to treat cancer |
